Previous studies have found that postmenopausal women who have taken a combined estrogen and progestin hormone replacement therapy have increased their risk of developing progestin-accelerated breast tumors. Now, University of Missouri researchers have found that curcumin, a popular Indian spice derived from the turmeric root, could reduce the cancer risk for women after exposure to hormone replacement therapy.

The risk of developing breast cancer due to taking hormone replacement therapy appears to be the same for women with a family history of breast cancer and without a family history, a University of Rochester Medical Center study concluded.

From the end of the 1970s to the late 1990s there was a significant reduction in the incidence of hip and distal forearm fractures among Oslo women in the early phase after menopause. Part of this decline can be explained by the large increase in the use of hormone replacement therapy after menopause in the same period, a new study shows.

Postmenopausal women are at an increased risk of developing coronary artery disease, yet recent research studies have sometimes resulted in conflicting data regarding how best to treat or minimize the effects of the disease.

Hormone replacement therapy (HRT) given in skin patches may cause fewer blood clots than HRT given orally, according to a report published on BMJ.com today. Furthermore, women who take the oral form of HRT more than double their risk of developing a blood clot, say the authors.

Hormone replacement therapy, which is known to increase the risk of breast cancer, also appears to make it more likely a tumor will return in women who have had the disease, researchers said on Tuesday.

Hormone replacement therapy (HRT) for peri- and postmenopausal symptoms increases disease recurrence in breast cancer survivors, according to an article published online March 25 in the Journal of the National Cancer Institute.

Although rheumatoid arthritis (RA) is more predominant in women, the reasons for this are unclear. Many studies have examined the effects of estrogen on the risk and severity of RA, but the results are conflicting and controversial.

Women who take hormone replacement therapy to ease menopause symptoms have abnormal mammogram results. This makes breast biopsies hard to be detected by doctors.

Hormone replacement therapy poses a risk for women to develop breast cancer. This risk is only a little higher, but many women undergoing the therapy will worry a lot more about abnormal mammograms or decide to have breast biopsy which they could avoid under different circumstances.

Menopausal women are at relatively high risk for memory loss, high blood pressure (hypertension) and diabetes. A decade ago, the standard treatment for these problems was long-term hormone replacement therapy (HRT).

For decades, older women have taken hormone replacements to replenish estrogen and progesterone levels lost to aging. More recently, testosterone (the most important male hormone) supplements have been used by aging men to improve their muscle mass, bone strength, libido and quality of life.